N16I (p.Asn16Ile) variant of BRD2 (Bromodomain-containing protein 2)
N16I (p.Asn16Ile) in BRD2 (Bromodomain-containing protein 2) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The record also includes structural context.
N16I (p.Asn16Ile) variant details
- p.Asn16Ile
- NCI-TCGA Cosmic COSV6637
- cosmic curated COSV66374
- Variant assessed as somatic; moderate impact.
- Missense
- UniProt: Variant assessed as somatic; moderate impact.
- Structural context available